z-logo
open-access-imgOpen Access
PHARMACEUTICAL AND ANALYTICAL STUDY ON DIFFERENT PARTS OF ASHOKA [SARACA ASOCA ROXB. DE WILDE.]
Author(s) -
Soumya M Saraswathi,
Subrahmanya Padyana
Publication year - 2021
Publication title -
international journal of research in ayurveda and pharmacy
Language(s) - English
Resource type - Journals
eISSN - 2277-4343
pISSN - 2229-3566
DOI - 10.7897/2277-4343.1205137
Subject(s) - traditional medicine , bark (sound) , medicine , phytochemical , biology , ecology
Presently Ayurvedic medicines are becoming ultimate medicine rather than alternative medicine. The plant Asoka (Saraca asoca Roxb.)is one of the important plants of the Indian system of medicine known for its numerous pharmacological activities. After analysing the physicochemical and phytochemical properties of different parts of Ashoka, various formulations of different parts of Ashoka have been prepared. Hence, to establish the different parts of Ashoka as medicine, an attempt has been made to conduct a pharmaceutical and analytical study on various parts of Ashoka. In the present study, it can be conclusively said that the face pack of the root powder is beneficial in blackish discolouration of the face, root ointment in acne and blackish discolouration of the face, stem syrup is beneficial in eczema and acne, stem powder soap is useful in skin disease, bark Kashaya in gynaecological disorders, bark syrup in dysfunctional uterine bleeding and anaemia, bark granules in general debility and anaemia, tender leaves Tambuli in gastritis, leaf ointment in acne, flower Tambuli in gastritis and menorrhagia, flower syrup in gastritis and seed powder is useful in urinary calculi and burning micturition. The pharmaceutical evaluation of all the prepared products of Ashoka was done and analysed systematically. The multiple formulations of different parts of Ashoka (S. asoca) which are useful as food and medicine are the outcomes of the present study

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here